Starting July 1, 2026, eligible people with Medicare Part D drug coverage can get certain GLP-1 medicines for weight loss for $50 for a monthly supply. CMS runs this as a time-limited demonstration called the Medicare GLP-1 Bridge, available through December 31, 2027.
What changed. CMS announced the program in May and launched it on July 1. It operates under the HHS Secretary’s authority to test new approaches to care, with CMS handling claims and payments to pharmacies centrally. CMS says enrollees can use it to obtain certain GLP-1 medicines “to lose weight or maintain weight reduction at a predictable and affordable cost of $50 per month.”
What it means. For people who qualify, the monthly cost of these drugs is fixed at $50. Eligibility rules apply. CMS directs beneficiaries to Medicare.gov to check whether they qualify and to talk with their doctor.
If you take this or are considering it. Start with eligibility, because CMS excludes people who already get a GLP-1 through Part D or are eligible for one there. You can check at Medicare.gov/glp1bridge or by calling 1-800-MEDICARE (1-800-633-4227; TTY 1-877-486-2048). Three details affect your budget. The $50 copay sits outside Part D, so the deductible does not apply, the copay does not count toward your yearly out-of-pocket total, and the low-income subsidy does not cover it. CMS also runs a prior authorization step through its central processor, so expect your prescriber to have a form to complete. The program ends December 31, 2027, which is worth raising before you start.
What has not changed. Not every enrollee qualifies. CMS says people who already get a GLP-1 through their existing Part D coverage, or who are eligible for one there, are excluded. The Bridge covers only certain products, it is temporary, and it does not apply to Medicaid or commercial insurance. The cheapest GLP-1 without insurance page compares the other routes.